http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108721282-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 |
| filingDate | 2018-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108721282-B |
| titleOfInvention | Application of UK383367 in preparation of medicine for relieving renal fibrosis related diseases |
| abstract | The invention discloses a new indication of UK383367, and provides that UK383367 can relieve renal interstitial fibrosis related diseases caused by unilateral ureteral ligation, including chronic renal diseases, renal interstitial fibrosis and other diseases, and mainly relieve chronic renal interstitial fibrosis by inhibiting the deposition of renal collagen. |
| priorityDate | 2018-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.